Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „study“
Suchtreffer
Begriffe & Kennungen
Afqlir · 4.8 · Serious ocular adverse reactions in the study eye related to the injection procedure have occurred in less tha
Eintrag öffnenAhzantive · 4.8 · Serious ocular adverse reactions in the study eye related to the injection procedure have occurred in less tha
Eintrag öffnenAhzantive · 4.8 · Serious ocular adverse reactions in the study eye related to the injection procedure have occurred in less tha
Eintrag öffnenAkeega · 4.5 · CYP2C8 substrates Abiraterone is an inhibitor of CYP2C8. In a clinical study in healthy subjects, the AUC of p
Eintrag öffnenAkeega · 4.5 · In a separate clinical study in healthy subjects, co-administration of ketoconazole, a strong inhibitor of CYP
Eintrag öffnenAkeega · 4.5 · Pharmacokinetic interactions No clinical study evaluating drug interactions has been performed using Akeega. I
Eintrag öffnenAkynzeo · 4.5 · In vitro data show that netupitant is a P-gp inhibitor. In a study performed in healthy volunteers, netupitant
Eintrag öffnenAldurazyme · 4.8 · In a phase 4 study 33 MPS I patients received 1 of 4 dose regimens: 100 U/kg IV every week (recommended dose),
Eintrag öffnenAldurazyme · 4.8 · Paediatric population ADRs to Aldurazyme reported during a Phase 2 study in a total of 20 patients, under 5 ye
Eintrag öffnenAldurazyme · 4.8 · Tabulated list of adverse reactions ADRs to Aldurazyme reported during the Phase 3 study and its extension in
Eintrag öffnenAlli (previously Orlistat GSK) · 4.5 · A decrease in ciclosporin plasma levels has been observed in a drug-drug interaction study and also reported i
Eintrag öffnenAloxi · 4.5 · In a clinical study, no significant pharmacokinetic interaction was shown between a single intravenous dose of
Eintrag öffnenAloxi · 4.5 · Metoclopramide In a clinical study, no significant pharmacokinetic interaction was shown between a single intr
Eintrag öffnenAlprolix · 4.8 · Description of selected adverse reactions Throughout the clinical study program, one patient (previously untre
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · In a clinical study in healthy volunteers, steady-state dosing with ambrisentan 10 mg once daily did not signi
Eintrag öffnenAnomalie der Elektrophysiologie des peripheren Nervensystems
Eintrag öffnenAnzupgo · 4.8 · The event rate of application site reactions in the long-term extension study (0.56 events per 100 patient yea
Eintrag öffnenApixaban Accord · 4.5 · In study CV185325, no clinically important bleeding events were reported in the 12 paediatric patients treated
Eintrag öffnenApixaban Accord · 4.5 · In study CV185325, no clinically important bleeding events were reported in the 12 paediatric patients treated
Eintrag öffnenApixaban Accord · 4.8 · The frequencies of adverse reactions reported in Table 3 for paediatric patients are derived from study CV1853
Eintrag öffnen